A experimental study on endostatin treatment for breast cancer in mice

Liu Lei,Yu Changjun,Wang Jin

2006-01-01

Abstract:Objective To study the effects of endostatin on the growth and metastasis of breast cancer. Methods Human breast cancer model was established by hypodermic implantation of histologically intact tumor tissue into nude mice. Endostatin was administered sc with dose of 20.0,10.0 and 0 mg/kg every other day for seven weeks. Eight weeks after implantation, tumor size, inhibition rate, intratumoral microvessel density, apoptotic index, and the presence of metastasis were evaluated respectively after the mice were sacrificed. Results Compared with the untreated control, growth of the tumor was significantly reduced in size in mice treated with endostatin with an inhibition of rate 91.3%,58.4%,0 with the dosage of 20.0,10.0 and 0 mg/kg, respectively. The MVD was also decreased significantly in the treated mice (1.8±0.4)versus (4.6±0.9),(9.6±1.2). The AI was increased significantly in the treated mice(12.4±4.9)% versus (8.3±2.6)%,(3.2±0.8)%. The growth of breast cancer implanted in nude mice were significantly inhibited (P<0.05).The incidences of liver (lung) were also significantly inhibited in the treated mice with dose of 20 mg/kg (P<0.05). Conclusion Endostation can inhibit the growth and metastasis of human breast cancer implanted in nude mice effectively by inhibiting tumor angiogenesis and inducing apoptosis in breast cancer, and its effect is in a dose-dependent manner.